A [[cohort]] of patients is [[random]]ly divided into a development cohort and an internal [[validation]] cohort. Often two-thirds of the patients are used to make a prognostic model, and this model is then tested on the remaining one-third. [[Cross-validation]]. Cross-validation can be seen as an extension of the split-sample approach.